Copyright
©The Author(s) 2021.
World J Gastrointest Endosc. Dec 16, 2021; 13(12): 659-672
Published online Dec 16, 2021. doi: 10.4253/wjge.v13.i12.659
Published online Dec 16, 2021. doi: 10.4253/wjge.v13.i12.659
Table 6 Clinical outcomes of high and low-volume preparations according to different schedules, n (%)
Outcome | High volume day before (n = 482) | High volume split-dose (n = 389) | P value1 | Low volume day before (n = 583) | Low volume split-dose (n = 361) | P value1 |
PDR | 149 (30.9) | 134 (34.4) | 0.277 | 145 (24.9) | 92 (25.5) | 0.833 |
ADR | 108 (22.4) | 102 (26.2) | 0.191 | 103 (17.7) | 68 (18.8) | 0.650 |
AADR | 30 (6.2) | 26 (6.7) | 0.783 | 20 (3.4) | 15 (4.2) | 0.567 |
Cancer | 11 (2.3) | 8 (2.1) | 0.827 | 6 (1.0) | 9 (2.5) | 0.088 |
SDR | 5 (1.0) | 11 (2.8) | 0.050 | 8 (1.4) | 4 (1.1) | 1.000 |
- Citation: Occhipinti V, Soriani P, Bagolini F, Milani V, Rondonotti E, Annunziata ML, Cavallaro F, Vavassori S, Vecchi M, Pastorelli L, Tontini GE. Efficacy and tolerability of high and low-volume bowel preparation compared: A real-life single-blinded large-population study. World J Gastrointest Endosc 2021; 13(12): 659-672
- URL: https://www.wjgnet.com/1948-5190/full/v13/i12/659.htm
- DOI: https://dx.doi.org/10.4253/wjge.v13.i12.659